Clicky

Teva Pharmaceutical Industries(TEVA) News

Date Title
May 15 Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
May 15 Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
May 15 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
May 14 Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying
May 13 Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
May 12 Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
May 12 Teva's Bold $700M Gamble: Will It Be Enough to Rescue Its Plummeting Stock?
May 9 Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential
Apr 28 Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Apr 21 Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now
Mar 14 Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
Mar 11 Teva debuts global campaign encouraging people to get outside
Feb 24 Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
Feb 24 Teva and Alvotech launch ustekinumab biosimilar injection in US
Feb 24 Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug
Feb 22 Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Feb 21 Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
Feb 20 Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist
Feb 19 Is Teva Pharmaceutical (TEVA) Trading at a Discount?
Feb 18 Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)